10qdetective’s Activity

Wed Oct 8

Caps Pick

10qdetective made a pick in CAPS. 1:49 PM

Alcobra Pharmaceuticals (ADHD) will Outperform the S&P 500

Tue Sep 23

CAPS Outperform Pitch

10qdetective wrote about pSivida Limited (PSDV) . 4:59 PM

PSDV Outperform

Fiscal 4Q14 should provide some updates on Tethadur's development and with Iluvien's PDUFA coming on September 26th now is the appropriate time to enter for long term growth.

Caps Pick

10qdetective made a pick in CAPS. 4:59 PM

pSivida Limited (PSDV) will Outperform the S&P 500

CAPS Outperform Pitch

10qdetective wrote about CONATUS PHARMACEUTICALS INC (CNAT) . 4:47 PM

CNAT Outperform

Catalysts for a likely price reversal rest on positive news coming from multiple data readouts being released in the next six to 12 months on lead drug candidate, emricasan, including phase 2 results of in patients with non-alcoholic fatty liver [more]

Caps Pick

10qdetective made a pick in CAPS. 4:47 PM

CONATUS PHARMACEUTICALS INC (CNAT) will Outperform the S&P 500

Sun Mar 23

NL

Article

10qdetective published an article 8:13 PM

Can AbbVie's Legacy Products Deliver Further Growth?

AbbVie is spending more than 16% of annual sales to develop new drugs that will lesson the drug maker's dependence on the rheumatoid arthritis drug Humira. Fortunately, the Chicago-based drug manufacturer has a stable of off-patent, legacy drugs that [more]

Wed Mar 5

NL

Article

10qdetective published an article 4:00 PM

AbbVie's Humira Still a Growth Engine

A published survey of rheumatologists suggests that growth in key European markets for AbbVie’s (NYSE: ABBV) flagship drug Humira could stall as biosimilar options become more prevalent. Absent longer-term safety data on these follow-on drugs, Humira [more]

Fri Feb 28

NL

Article

10qdetective published an article 1:59 PM

Pfizer Stubs Toe Without Celebrex

Pfizer (NYSE: PFE) remains committed to maintaining a leadership position in global pain-treatment markets, despite the upcoming loss of market exclusivity for Celebrex. Foolish investors should remain wary of management promises.

Tue Feb 25

NL

Article

10qdetective published an article 11:13 AM

Zogenix Stockholders Facing World of Pain?

The share price of Zogenix has soared more than 260% during the past year, driven by investor optimism for new opioid painkiller Zyhydro ER. Will the drug be a commercial success?

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75070
Score 0.00
Score Change Today +0.84
Accuracy 0.00%
Active Picks 6
Total Picks 9
Best Pick SCTY (+47.30)
Worst Pick GORO (-48.82)
Average Score per Pick -13.56
Charms Earned 3
Highest Rated Favorite No Favorites Selected
Go to 10qdetective’s CAPS page

Boards Stats & Trivia

Board Posts 3
Recs Received 2
People who have rec'd these posts 2
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board Electronic Arts Inc.
Very First Post Re: Cadmium/Tellurium Issues? (8/6/2008)
Percentage of Posts Rec'd 33.33 %
Show 10qdetective’s 10 Latest Posts